Bridging Discovery to Clinic: How AI and Digital Technologies Are Transforming Therapeutics
Bridging Discovery to Clinic: How AI and Digital Technologies Are Transforming Therapeutics
Discover how technology is transforming therapeutics, reducing time-to-market, and cutting development costs.
We are entering a new era where artificial intelligence, digital technology, and next-generation engineering are converging to reshape the entire therapeutic lifecycle — from discovery and design to development, trials, manufacturing, and patient delivery.
This convergence is redefining how quickly and affordably treatments reach patients, marking a pivotal shift in efficiency, precision, and innovation velocity across life sciences. It is no surprise that capital allocation is concentrating in fewer, later-stage deals, with AI-driven discovery remaining a key investment bright spot. Join us for an afternoon panel discussion exploring how promising, high-impact companies are leveraging technology to reimagine the therapeutic lifecycle through AI, data, and digital integration.
Panelists:
Jonathan Steckbeck, CEO & Founder, Peptilogics
Andreas Pfenning, Associate Professor of Computational Biology, Carnegie Mellon University
Amoolya Singh, Chief Technology Officer, DELFI Diagnostics
Dana Watt, Partner, Breakout Ventures
Megan Shaw (moderator), President & CEO, Pittsburgh Life Sciences Alliance
Co-hosted by the CMU Swartz Center for Entrepreneurship and the Pittsburgh Life Sciences Alliance.
Sunday, January 11, 2026
2-4 PM (PT)
RSVP requested by Jan 2. Check back often for speaker updates.